{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T04:10:50Z","timestamp":1789099850962,"version":"build-2803163510"},"reference-count":56,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,29]],"date-time":"2025-07-29T00:00:00Z","timestamp":1753747200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,29]],"date-time":"2025-07-29T00:00:00Z","timestamp":1753747200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100017035","name":"Center for AIDS Research, Johns Hopkins University","doi-asserted-by":"publisher","award":["P30AI094189"],"award-info":[{"award-number":["P30AI094189"]}],"id":[{"id":"10.13039\/100017035","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01MH132150"],"award-info":[{"award-number":["R01MH132150"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Public Health"],"DOI":"10.1186\/s12889-025-23775-0","type":"journal-article","created":{"date-parts":[[2025,7,29]],"date-time":"2025-07-29T10:36:58Z","timestamp":1753785418000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["HIV Pre-exposure prophylaxis (PrEP) modalities and service delivery preferences among black cisgender emerging and older adult women in Baltimore, Maryland"],"prefix":"10.1186","volume":"25","author":[{"given":"Deja","family":"Knight","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haneefa","family":"Saleem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Baral","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle","family":"German","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiara C.","family":"Willie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,29]]},"reference":[{"key":"23775_CR1","unstructured":"Centers for Disease Control and Prevention. HIV Surveillance Report, 2018 (Updated). 2020:31. Available at: http:\/\/www.cdc.gov\/hiv\/library\/reports\/hiv-surveillance.html. Accessed 4 Apr 2024."},{"issue":"4","key":"23775_CR2","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.annepidem.2017.02.003","volume":"27","author":"KL Hess","year":"2017","unstructured":"Hess KL, Hu X, Lansky A, Mermin J, Hall IH. Lifetime risk of a diagnosis of HIV infection in the United States. Ann Epidemiol. 2017;27(4):238\u201343.","journal-title":"Ann Epidemiol"},{"key":"23775_CR3","unstructured":"Centers for Disease Control and Prevention. Diagnoses of HIV infection in the United States and dependent areas, 2021. HIV Surveillance Rep. 2023;34. https:\/\/www.natap.org\/2023\/HIV\/052523_04.htm."},{"key":"23775_CR4","unstructured":"Centers for Disease Control and Prevention. About PrEP 2022. https:\/\/www.cdc.gov\/hiv\/basics\/prep\/about-prep.html. Accessed 2 Apr 2024."},{"key":"23775_CR5","unstructured":"Centers for Disease Control and Prevention. PrEP Effectiveness 2022. https:\/\/www.cdc.gov\/hiv\/basics\/prep\/prep-effectiveness.html. Accessed 2 Apr 2024."},{"key":"23775_CR6","unstructured":"Centers for Disease Control and Prevention. HIV and Black\/African American People in the U.S. 2022. https:\/\/www.cdc.gov\/nchhstp\/newsroom\/fact-sheets\/hiv\/black-african-american-factsheet.html. Accessed 2 April 2024."},{"key":"23775_CR7","unstructured":"Centers for Disease Control and Prevention. Truvada Medication Information Sheet. chrome-extension:\/\/efaidnbmnnnibpcajpcglclefindmkaj\/https:\/\/www.cdc.gov\/hiv\/pdf\/prep_gl_patient_factsheet_truvada_english.pdf. Accessed 2 Apr 2024."},{"key":"23775_CR8","unstructured":"Apretude W. Apretude 2023. https:\/\/apretude.com\/about-apretude\/what-is-apretude\/. Accessed 2 Apr 2024."},{"key":"23775_CR9","unstructured":"PrEPWATCH. The Dapivirine Vaginal Ring. 2023. https:\/\/www.prepwatch.org\/products\/the-dapivirine-vaginal-ring\/. Accessed 2 Apr 2024."},{"issue":"7","key":"23775_CR10","doi-asserted-by":"publisher","first-page":"2212","DOI":"10.1007\/s10461-021-03571-8","volume":"26","author":"WC Irie","year":"2022","unstructured":"Irie WC, Calabrese SK, Patel RR, Mayer KH, Geng EH, Marcus JL. Preferences for HIV preexposure prophylaxis products among black women in the US. AIDS Behav. 2022;26(7):2212\u201323.","journal-title":"AIDS Behav"},{"key":"23775_CR11","doi-asserted-by":"crossref","unstructured":"Johnson AK, Ott E, Friedman E, Moore A, Alvarez I, Pandiani A, et al. Exploring pre-exposure prophylaxis (PrEP) modality preferences among black cisgender women attending family planning clinics in Chicago. BMJ Public Health. 2025:3(1).","DOI":"10.1136\/bmjph-2023-000809"},{"issue":"3","key":"23775_CR12","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1089\/apc.2019.0242","volume":"34","author":"SK Calabrese","year":"2020","unstructured":"Calabrese SK, Galvao RW, Dovidio JF, Willie TC, Safon CB, Kaplan C, et al. Contraception as a potential gateway to pre-exposure prophylaxis: US women\u2019s pre-exposure prophylaxis modality preferences align with their birth control practices. AIDS Patient Care STDs. 2020;34(3):132\u201346.","journal-title":"AIDS Patient Care STDs"},{"issue":"10","key":"23775_CR13","doi-asserted-by":"publisher","first-page":"1207","DOI":"10.1080\/09540121.2019.1587352","volume":"31","author":"KH Footer","year":"2019","unstructured":"Footer KH, Lim S, Rael CT, Greene GJ, Carballa-Di\u00e9guez A, Giguere R, et al. Exploring new and existing PrEP modalities among female sex workers and women who inject drugs in a US City. AIDS Care. 2019;31(10):1207\u201313.","journal-title":"AIDS Care"},{"key":"23775_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10461-022-03691-9","volume":"26","author":"L Elopre","year":"2022","unstructured":"Elopre L, Boutwell A, Gordon B, Johnson B, Marrazzo J, Van Der Pol B, et al. PrEP service delivery preferences of black Cis-gender women living in the Southern United States. AIDS Behav. 2022;26:1\u201311.","journal-title":"AIDS Behav"},{"issue":"5","key":"23775_CR15","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1097\/QAI.0000000000002377","volume":"84","author":"LR Hirschhorn","year":"2020","unstructured":"Hirschhorn LR, Brown RN, Friedman EE, Greene GJ, Bender A, Christeller C, et al. Black cisgender women\u2019s PrEP knowledge, attitudes, preferences and experience in Chicago. J Acquir Immune Defic Syndr. 2020;84(5):497.","journal-title":"J Acquir Immune Defic Syndr"},{"key":"23775_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12913-020-05568-w","volume":"20","author":"J Vanhamel","year":"2020","unstructured":"Vanhamel J, Rotsaert A, Reyniers T, N\u00f6stlinger C, Laga M, Van Landeghem E, et al. The current landscape of pre-exposure prophylaxis service delivery models for HIV prevention: a scoping review. BMC Health Serv Res. 2020;20:1\u201318.","journal-title":"BMC Health Serv Res"},{"key":"23775_CR17","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1080\/09540121.2019.1619665","volume":"31","author":"TS Torres","year":"2019","unstructured":"Torres TS, Luz PM, De Boni RB, de Vasconcellos MT, Hoagland B, Garner A, et al. Factors associated with PrEP awareness according to age and willingness to use HIV prevention technologies: the 2017 online survey among MSM in Brazil. AIDS Care. 2019;31:1193.","journal-title":"AIDS Care."},{"issue":"10","key":"23775_CR18","doi-asserted-by":"publisher","first-page":"e0285132","DOI":"10.1371\/journal.pone.0285132","volume":"18","author":"A Kakande","year":"2023","unstructured":"Kakande A, Ssemata AS, Muhumuza R, Atujuna M, Abaasa A, Ndekezi D, et al. Preferences for oral PrEP dosing among adolescent boys and young men in three sub-Saharan African countries. PLoS ONE. 2023;18(10):e0285132.","journal-title":"PLoS ONE"},{"issue":"2","key":"23775_CR19","doi-asserted-by":"publisher","first-page":"277","DOI":"10.18865\/ed.30.2.277","volume":"30","author":"T Taggart","year":"2020","unstructured":"Taggart T, Milburn NG, Nyhan K, Ritchwood TD. Utilizing a life course approach to examine HIV risk for black adolescent girls and young adult women in the United States: a systematic review of recent literature. Ethn Dis. 2020;30(2):277.","journal-title":"Ethn Dis"},{"issue":"6","key":"23775_CR20","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1521\/aeap.2010.22.6.509","volume":"22","author":"MM Johns","year":"2010","unstructured":"Johns MM, Bauermeister JA, Zimmerman MA. Individual and neighborhood correlates of HIV testing among African American youth transitioning from adolescence into young adulthood. AIDS Educ Prev. 2010;22(6):509\u201322.","journal-title":"AIDS Educ Prev"},{"issue":"9","key":"23775_CR21","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1001\/jama.2019.1343","volume":"321","author":"AS Fauci","year":"2019","unstructured":"Fauci AS, Redfield RR, Sigounas G, Weahkee MD, Giroir BP. Ending the HIV epidemic: a plan for the United States. JAMA. 2019;321(9):844\u20135.","journal-title":"JAMA"},{"issue":"3","key":"23775_CR22","doi-asserted-by":"publisher","first-page":"1414","DOI":"10.3390\/ijerph19031414","volume":"19","author":"R Chandler","year":"2022","unstructured":"Chandler R, Guillaume D, Wells J, Hernandez N. Let me Prep you to PREP me: amplifying the voices of black women and their providers to consider PrEP as an HIV prevention option. Int J Environ Res Public Health. 2022;19(3):1414.","journal-title":"Int J Environ Res Public Health"},{"issue":"6","key":"23775_CR23","doi-asserted-by":"publisher","first-page":"2744","DOI":"10.1007\/s40615-022-01452-x","volume":"10","author":"T Arnold","year":"2022","unstructured":"Arnold T, Whiteley L, Elwy RA, Ward LM, Konkle-Parker DJ, Brock JB, et al. Mapping implementation science with expert recommendations for implementing change (MIS-ERIC): strategies to improve PrEP use among black cisgender women living in Mississippi. J Racial Ethnic Health Disparities. 2022;10(6):2744\u201361.","journal-title":"J Racial Ethnic Health Disparities"},{"issue":"1","key":"23775_CR24","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.1186\/s12889-022-13999-9","volume":"22","author":"TC Willie","year":"2022","unstructured":"Willie TC, Knight D, Baral SD, Chan PA, Kershaw T, Mayer KH, et al. Where\u2019S the everyday black woman?? An intersectional qualitative analysis of black women\u2019s Decision-Making regarding HIV Pre-Exposure prophylaxis (PrEP) in Mississippi. BMC Public Health. 2022;22(1):1604.","journal-title":"BMC Public Health"},{"key":"23775_CR25","unstructured":"United States Census Bureau. Quick Facts Baltimore City, Maryland. 2021. https:\/\/www.census.gov\/quickfacts\/fact\/table\/baltimorecitymaryland\/PST045223. Accessed 4 Apr 2024."},{"key":"23775_CR26","unstructured":"AIDSVu. Local Data: Baltimore City, MD 2019. https:\/\/aidsvu.org\/local-data\/united-states\/south\/maryland\/baltimore-city\/. Accessed 2 Apr 2024."},{"key":"23775_CR27","unstructured":"Centers for Disease Control and Prevention. US Public Health Service. Preexposure prophylaxis for the prevention of HIV infection in the United States\u20142021 update: a clinical practice guideline. Atlanta, GA: Centers for Disease Control and Prevention; 2021."},{"key":"23775_CR28","volume-title":"MAXQDA 2022 [computer software]","author":"VERBI Software","year":"2021","unstructured":"VERBI Software. MAXQDA 2022 [computer software]. Berlin, Germany: VERBI Software; 2021."},{"key":"23775_CR29","unstructured":"Maxwell JA. Qualitative research design: an interactive approach. Sage; 2012."},{"key":"23775_CR30","unstructured":"Creswell J. Qualitative inquiry and research design: choosing among five approaches. 2nd ed. Sage; 2007."},{"issue":"7226","key":"23775_CR31","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1136\/bmj.320.7226.50","volume":"320","author":"N Mays","year":"2000","unstructured":"Mays N, Pope C. Assessing quality in qualitative research. BMJ. 2000;320(7226):50\u20132.","journal-title":"BMJ"},{"issue":"7","key":"23775_CR32","doi-asserted-by":"publisher","first-page":"305","DOI":"10.1089\/apc.2017.0075","volume":"31","author":"A van der Straten","year":"2017","unstructured":"van der Straten A, Shapley-Quinn MK, Reddy K, Cheng H, Etima J, Woeber K, et al. Favoring peace of mind: A qualitative study of African women\u2019s HIV prevention product formulation preferences from the MTN-020\/ASPIRE trial. AIDS Patient Care STDs. 2017;31(7):305\u201314.","journal-title":"AIDS Patient Care STDs"},{"issue":"3","key":"23775_CR33","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1007\/s40615-021-01020-9","volume":"9","author":"M Pyra","year":"2021","unstructured":"Pyra M, Johnson AK, Devlin S, Uvin AZ, Irby S, Stewart E, et al. HIV pre-exposure prophylaxis use and persistence among black ciswomen:women need to protect themselves, period. J Racial Ethnic Health Disparities. 2021;9(3):820\u20139.","journal-title":"J Racial Ethnic Health Disparities"},{"issue":"1","key":"23775_CR34","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12889-022-14149-x","volume":"22","author":"AL Cochran","year":"2022","unstructured":"Cochran AL, McDonald NC, Prunkl L, Vinella-Brusher E, Wang J, Oluyede L, et al. Transportation barriers to care among frequent health care users during the COVID pandemic. BMC Public Health. 2022;22(1):1\u201310.","journal-title":"BMC Public Health"},{"key":"23775_CR35","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1007\/s10900-013-9681-1","volume":"38","author":"ST Syed","year":"2013","unstructured":"Syed ST, Gerber BS, Sharp LK. Traveling towards disease: transportation barriers to health care access. J Community Health. 2013;38:976\u201393.","journal-title":"J Community Health"},{"issue":"7","key":"23775_CR36","doi-asserted-by":"publisher","first-page":"e2325291","DOI":"10.1001\/jamanetworkopen.2023.25291","volume":"6","author":"M Labban","year":"2023","unstructured":"Labban M, Chen C-R, Frego N, Nguyen D-D, Lipsitz SR, Reich AJ, et al. Disparities in travel-Related barriers to accessing health care from the 2017 National household travel survey. JAMA Netw Open. 2023;6(7):e2325291\u2013e.","journal-title":"JAMA Netw Open"},{"issue":"4","key":"23775_CR37","doi-asserted-by":"publisher","first-page":"e20173402","DOI":"10.1542\/peds.2017-3402","volume":"141","author":"C Hensley","year":"2018","unstructured":"Hensley C, Heaton PC, Kahn RS, Luder HR, Frede SM, Beck AF. Poverty, transportation access, and medication nonadherence. Pediatrics. 2018;141(4):e20173402.","journal-title":"Pediatrics."},{"issue":"2","key":"23775_CR38","first-page":"178","volume":"18","author":"SM Locatelli","year":"2017","unstructured":"Locatelli SM, Sharp LK, Syed ST, Bhansari S, Gerber BS. Measuring health-related transportation barriers in urban settings. J Appl Meas. 2017;18(2):178.","journal-title":"J Appl Meas"},{"issue":"3","key":"23775_CR39","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1080\/09540121.2013.819403","volume":"26","author":"LM Sagrestano","year":"2014","unstructured":"Sagrestano LM, Clay J, Finerman R, Gooch J, Rapino M. Transportation vulnerability as a barrier to service utilization for HIV-positive individuals. AIDS Care. 2014;26(3):314\u20139.","journal-title":"AIDS Care"},{"issue":"7","key":"23775_CR40","doi-asserted-by":"publisher","first-page":"2148","DOI":"10.1007\/s10461-021-03560-x","volume":"26","author":"CN Pope","year":"2022","unstructured":"Pope CN, Stavrinos D, Fazeli PL, Vance DE. Transportation barriers and health-related quality of life in a sample of middle-aged and older adults living with HIV in the deep South. AIDS Behav. 2022;26(7):2148\u201358.","journal-title":"AIDS Behav"},{"issue":"11","key":"23775_CR41","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1080\/09540121.2018.1476656","volume":"30","author":"AD Kimmel","year":"2018","unstructured":"Kimmel AD, Masiano SP, Bono RS, Martin EG, Belgrave FZ, Adimora AA, et al. Structural barriers to comprehensive, coordinated HIV care: geographic accessibility in the US South. AIDS Care. 2018;30(11):1459\u201368.","journal-title":"AIDS Care"},{"issue":"11","key":"23775_CR42","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1080\/09540121.2022.2029816","volume":"34","author":"SE Harrison","year":"2022","unstructured":"Harrison SE, Paton M, Muessig KE, Vecchio AC, Hanson LA, Hightow-Weidman LB. Do I want PrEP or do I want a roof? Social determinants of health and HIV prevention in the Southern United States. AIDS Care. 2022;34(11):1435\u201342.","journal-title":"AIDS Care"},{"key":"23775_CR43","doi-asserted-by":"publisher","first-page":"2301","DOI":"10.1007\/s10461-021-03159-2","volume":"25","author":"A Ogunbajo","year":"2021","unstructured":"Ogunbajo A, Storholm ED, Ober AJ, Bogart LM, Reback CJ, Flynn R, et al. Multilevel barriers to HIV PrEP uptake and adherence among black and hispanic\/latinx transgender women in Southern California. AIDS Behav. 2021;25:2301\u201315.","journal-title":"AIDS Behav"},{"key":"23775_CR44","doi-asserted-by":"publisher","first-page":"1778","DOI":"10.1007\/s12325-020-01295-0","volume":"37","author":"KH Mayer","year":"2020","unstructured":"Mayer KH, Agwu A, Malebranche D. Barriers to the wider use of pre-exposure prophylaxis in the United States: a narrative review. Adv Therapy. 2020;37:1778\u2013811.","journal-title":"Adv Therapy"},{"key":"23775_CR45","doi-asserted-by":"crossref","unstructured":"Ojikutu BO, Bogart LM, Mayer KH, Stopka TJ, Sullivan PS, Ransome Y. Spatial access and willingness to use pre-exposure prophylaxis among Black\/African American individuals in the United States: cross-sectional survey. JMIR Public Health Surveillance. 2019;5(1):e12405.","DOI":"10.2196\/12405"},{"issue":"2","key":"23775_CR46","doi-asserted-by":"publisher","first-page":"e25667","DOI":"10.1002\/jia2.25667","volume":"24","author":"J Zhang","year":"2021","unstructured":"Zhang J, Xu JJ, Wang HY, Huang XJ, Chen YK, Wang H, et al. Preference for daily versus on-demand pre\u2010exposure prophylaxis for HIV and correlates among men who have sex with men: the China Real\u2010world oral PrEP demonstration study. J Int AIDS Soc. 2021;24(2):e25667.","journal-title":"J Int AIDS Soc"},{"issue":"5","key":"23775_CR47","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1080\/09540121.2018.1557590","volume":"31","author":"A Dubov","year":"2019","unstructured":"Dubov A, Ogunbajo A, Altice FL, Fraenkel L. Optimizing access to PrEP based on MSM preferences: results of a discrete choice experiment. AIDS Care. 2019;31(5):545\u201353.","journal-title":"AIDS Care"},{"issue":"6","key":"23775_CR48","doi-asserted-by":"publisher","first-page":"e37479","DOI":"10.2196\/37479","volume":"8","author":"P Patel","year":"2022","unstructured":"Patel P, Kerzner M, Reed JB, Sullivan PS, El-Sadr WM. Public health implications of adapting HIV pre-exposure prophylaxis programs for virtual service delivery in the context of the COVID-19 pandemic: systematic review. JMIR Public Health Surveillance. 2022;8(6):e37479.","journal-title":"JMIR Public Health Surveillance"},{"issue":"5","key":"23775_CR49","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1007\/s11904-022-00617-x","volume":"19","author":"C Kiptinness","year":"2022","unstructured":"Kiptinness C, Kuo AP, Reedy AM, Johnson CC, Ngure K, Wagner AD, et al. Examining the use of HIV self-testing to support PrEP delivery: a systematic literature review. Curr HIV\/AIDS Rep. 2022;19(5):394\u2013408.","journal-title":"Curr HIV\/AIDS Rep"},{"issue":"5","key":"23775_CR50","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10461-021-03494-4","volume":"26","author":"A Zhao","year":"2022","unstructured":"Zhao A, Dangerfield DT, Nunn A, Patel R, Farley JE, Ugoji CC, et al. Pharmacy-based interventions to increase use of HIV pre-exposure prophylaxis in the United States: a scoping review. AIDS Behav. 2022;26(5):1\u201316.","journal-title":"AIDS Behav"},{"key":"23775_CR51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13063-021-05402-6","volume":"22","author":"A Medina-Marino","year":"2021","unstructured":"Medina-Marino A, Bezuidenhout D, Hosek S, Barnabas RV, Atujuna M, Bezuidenhout C, et al. The community PrEP study: a randomized control trial leveraging community-based platforms to improve access and adherence to pre-exposure prophylaxis to prevent HIV among adolescent girls and young women in South Africa\u2014study protocol. Trials. 2021;22:1\u201314.","journal-title":"Trials"},{"issue":"1","key":"23775_CR52","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1186\/s12913-023-10277-1","volume":"23","author":"SA Butts","year":"2023","unstructured":"Butts SA, Young B, Blackmon J, Doblecki-Lewis S. Addressing disparities in Pre-exposure prophylaxis (PrEP) access: implementing a community-centered mobile PrEP program in South Florida. BMC Health Serv Res. 2023;23(1):1311.","journal-title":"BMC Health Serv Res"},{"issue":"1","key":"23775_CR53","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12889-020-09248-6","volume":"20","author":"R Chandler","year":"2020","unstructured":"Chandler R, Hull S, Ross H, Guillaume D, Paul S, Dera N, et al. The pre-exposure prophylaxis (PrEP) consciousness of black college women and the perceived hesitancy of public health institutions to curtail HIV in black women. BMC Public Health. 2020;20(1):1\u201311.","journal-title":"BMC Public Health"},{"issue":"12","key":"23775_CR54","doi-asserted-by":"publisher","first-page":"4225","DOI":"10.1007\/s10461-021-03287-9","volume":"25","author":"SZ Kudrati","year":"2021","unstructured":"Kudrati SZ, Hayashi K, Taggart T. Social media & prep: A systematic review of social media campaigns to increase PrEP awareness & uptake among young black and Latinx MSM and women. AIDS Behav. 2021;25(12):4225\u201334.","journal-title":"AIDS Behav"},{"issue":"8","key":"23775_CR55","doi-asserted-by":"publisher","first-page":"e11375","DOI":"10.2196\/11375","volume":"7","author":"VV Patel","year":"2018","unstructured":"Patel VV, Ginsburg Z, Golub SA, Horvath KJ, Rios N, Mayer KH, et al. Empowering with PrEP (E-PrEP), a peer-led social media\u2013based intervention to facilitate HIV preexposure prophylaxis adoption among young black and Latinx gay and bisexual men: protocol for a cluster randomized controlled trial. JMIR Res Protocols. 2018;7(8):e11375.","journal-title":"JMIR Res Protocols"},{"issue":"6","key":"23775_CR56","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11904-021-00576-9","volume":"18","author":"E Irungu","year":"2021","unstructured":"Irungu E, Khoza N, Velloza J. Multi-level interventions to promote oral pre-exposure prophylaxis use among adolescent girls and young women: a review of recent research. Curr HIV\/AIDS Rep. 2021;18(6):1\u201310.","journal-title":"Curr HIV\/AIDS Rep"}],"container-title":["BMC Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-025-23775-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12889-025-23775-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12889-025-23775-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,8]],"date-time":"2025-09-08T07:19:01Z","timestamp":1757315941000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpublichealth.biomedcentral.com\/articles\/10.1186\/s12889-025-23775-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,29]]},"references-count":56,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["23775"],"URL":"https:\/\/doi.org\/10.1186\/s12889-025-23775-0","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-5112395\/v1","asserted-by":"object"}]},"ISSN":["1471-2458"],"issn-type":[{"value":"1471-2458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,29]]},"assertion":[{"value":"18 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All study procedures were approved by the Johns Hopkins Bloomberg School of Public Health Institutional Review Board (#IRB00017507). Verbal informed consent was obtained from participants prior to the start of the focus group discussion or interview. Participants were informed that they could withdraw their consent at any time. Verbal consent was appropriate for this study because sensitive information was collected, and the collection of a signature might have increased the risk for participants.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2579"}}